课题基金 / 基金详情

SOCA: GANCICLOVIR-CIDOFOVIR CMV RETINITIS TRIAL

SOCA: GANCICLOVIR-CIDOFOVIR CMV RETINITIS TRIAL
SOCA:更昔洛韦-西多福韦 CMV 视网膜炎试验
批准号:
6264634
负责人:
DOROTHY Nahm FRIEDBERG
金额:
$2.1万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

DOROTHY Nahm FRIEDBERG的其他基金

相似基金

相关文献

中文摘要
翻译
这项IV期、随机、平行设计的试验研究了两种治疗方案(更昔洛韦眼内装置和口服更昔洛韦vs. IV西多福韦),这些治疗方案不使用中心静脉导管,用于新诊断和复发的艾滋病相关CMV视网膜炎。主要目的是比较两种方案在预防视力丧失方面的疗效。 次要目的是比较结合高度活性局部治疗的治疗方案与不结合的治疗方案。
英文摘要
This Phase IV , randomized, parallel design trial is the study of two treatment regimens (ganciclovir intraocular device & oral ganciclovir vs. IV cidofovir) that are administered without the use of a central venous catheter for both newly diagnosed and relapsed AIDS-related CMV retinitis. The primary objective is to compare the two regimens with respect to efficacy in preventing vision loss. A secondary objective is to compare a treatment which incorporates highly active local therapy with a treatment regimen that does not.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SOCA: LONGITUDINAL STUDY OF THE OCULAR COMPLICATIONS OF AIDS
SOCA: LONGITUDINAL STUDY OF THE OCULAR COMPLICATIONS OF AIDS
SOCA: LONGITUDINAL STUDY OF THE OCULAR COMPLICATIONS OF AIDS
SOCA: LONGITUDINAL STUDY OF THE OCULAR COMPLICATIONS OF AIDS
海外基金